Recent Finacing
Recent Raise
PanOptica is a biopharmaceutical company developing PAN-90806, a topical small-molecule VEGF inhibitor eye drop for neovascular retinal diseases, advancing suspension formulations through early clinical and preclinical studies.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors